AHSG confers apoptosis resistance in lung adenocarcinoma by modulating the GSK3β/β-catenin axis

preprint OA: closed
Full text JSON View at publisher
AI-generated deep summary by claude@2026-07, 2026-07-04 · read from full text

This preprint studied how alpha-2-Heremans-Schmid glycoprotein (AHSG) regulates apoptosis in lung adenocarcinoma, focusing on elevated cytoplasmic AHSG and its effects on intracellular signaling. The authors report that cytoplasmic AHSG interacts with GSK3β, promoting TRAF6-mediated ubiquitination and degradation of GSK3β, which relieves repression of β-catenin, drives β-catenin nuclear translocation, and inhibits apoptosis, thereby supporting tumor cell survival; they further state that AHSG ablation suppresses the GSK3β/β-catenin pathway and induces apoptosis. A key caveat explicitly noted is that the work has not been peer reviewed (it is a preprint). Relevance to endometriosis: this paper does not explicitly discuss endometriosis or adenomyosis; it was included in the corpus via a keyword match in the upstream search index.

Read from the paper's body, not the abstract. Not a substitute for reading the paper. No clinical advice. How this works

Abstract

Abstract Recent studies have demonstrated that alpha-2-Heremans-Schmid glycoprotein (AHSG) is significantly upregulated in lung adenocarcinoma (LUAD), where it correlates with poor prognosis and serves as an independent prognostic factor in LUAD patients. It promotes tumor progression by enhancing cell proliferation, migration, and invasion through modulation of TGFβ/PI3K-Akt signaling and induction of epithelial-mesenchymal transition (EMT). Although the proliferative effect of AHSG is well established, its role in regulating anti-apoptotic functions and the underlying molecular mechanisms remains unexplored. In the present study, we demonstrated that elevated cytoplasmic AHSG in LUAD serves as a critical regulator of programmed cell death by targeting the GSK3β/β-catenin axis. Mechanistically, cytoplasmic AHSG interacts with GSK3β and promotes its TRAF6-mediated ubiquitination and degradation, thereby relieving β-catenin repression and facilitating its nuclear translocation. Nuclear accumulation of β-catenin in LUAD cells considerably inhibits apoptosis, thereby promoting tumor survival. Interestingly, AHSG ablation markedly inhibited the GSK3β/β-catenin pathway, leading to induction of apoptosis in LUAD cells. These findings reveal a fundamental role of AHSG in driving LUAD cancer progression and suggest that targeting AHSG may be a potential therapeutic strategy for LUAD management.
Full text 13,597 characters · extracted from preprint-html · click to expand
AHSG confers apoptosis resistance in lung adenocarcinoma by modulating the GSK3β/β-catenin axis | Research Square window.SnipcartSettings = { analytics: { enabled: false } }; (function() { var accessVector = localStorage.getItem('access_vector') || ''; window.dataLayer = window.dataLayer || []; if (accessVector) { window.dataLayer.push({ user: { profile: { profileInfo: { snid: accessVector } } } }); } })(); (function(w,d,s,l,i){w[l]=w[l]||[];w[l].push({'gtm.start':new Date().getTime(),event:'gtm.js'});var f=d.getElementsByTagName(s)[0],j=d.createElement(s),dl=l!='dataLayer'?'&l='+l:'';j.async=true;j.src='https://www.googletagmanager.com/gtm.js?id='+i+dl;f.parentNode.insertBefore(j,f);})(window,document,'script','dataLayer','GTM-K279D39R'); Browse Preprints In Review Journals COVID-19 Preprints AJE Video Bytes Research Tools Research Promotion AJE Professional Editing AJE Rubriq About Preprint Platform In Review Editorial Policies Our Team Advisory Board Help Center Sign In Submit a Preprint Cite Share Download PDF Research Article AHSG confers apoptosis resistance in lung adenocarcinoma by modulating the GSK3β/β-catenin axis Moyna Kalia, Akanksha Kapoor, Deeksha Pal, Suman Dasgupta, Durba Pal This is a preprint; it has not been peer reviewed by a journal. https://doi.org/ 10.21203/rs.3.rs-9021786/v1 This work is licensed under a CC BY 4.0 License Status: Under Revision Version 1 posted 9 You are reading this latest preprint version Abstract Recent studies have demonstrated that alpha-2-Heremans-Schmid glycoprotein (AHSG) is significantly upregulated in lung adenocarcinoma (LUAD), where it correlates with poor prognosis and serves as an independent prognostic factor in LUAD patients. It promotes tumor progression by enhancing cell proliferation, migration, and invasion through modulation of TGFβ/PI3K-Akt signaling and induction of epithelial-mesenchymal transition (EMT). Although the proliferative effect of AHSG is well established, its role in regulating anti-apoptotic functions and the underlying molecular mechanisms remains unexplored. In the present study, we demonstrated that elevated cytoplasmic AHSG in LUAD serves as a critical regulator of programmed cell death by targeting the GSK3β/β-catenin axis. Mechanistically, cytoplasmic AHSG interacts with GSK3β and promotes its TRAF6-mediated ubiquitination and degradation, thereby relieving β-catenin repression and facilitating its nuclear translocation. Nuclear accumulation of β-catenin in LUAD cells considerably inhibits apoptosis, thereby promoting tumor survival. Interestingly, AHSG ablation markedly inhibited the GSK3β/β-catenin pathway, leading to induction of apoptosis in LUAD cells. These findings reveal a fundamental role of AHSG in driving LUAD cancer progression and suggest that targeting AHSG may be a potential therapeutic strategy for LUAD management. Lung adenocarcinoma AHSG GSK3β glycoprotein programmed cell death Full Text Additional Declarations No competing interests reported. Supplementary Files Supplementaryfinal.pdf Supplementaryfinalapoptosis.docx Cite Share Download PDF Status: Under Revision Version 1 posted Editorial decision: Revision requested 11 Apr, 2026 Reviews received at journal 07 Apr, 2026 Reviews received at journal 31 Mar, 2026 Reviewers agreed at journal 18 Mar, 2026 Reviewers agreed at journal 16 Mar, 2026 Reviewers invited by journal 13 Mar, 2026 Editor assigned by journal 04 Mar, 2026 Submission checks completed at journal 04 Mar, 2026 First submitted to journal 03 Mar, 2026 You are reading this latest preprint version Research Square lets you share your work early, gain feedback from the community, and start making changes to your manuscript prior to peer review in a journal. As a division of Research Square Company, we’re committed to making research communication faster, fairer, and more useful. We do this by developing innovative software and high quality services for the global research community. Our growing team is made up of researchers and industry professionals working together to solve the most critical problems facing scientific publishing. Also discoverable on Platform About Our Team In Review Editorial Policies Advisory Board Help Center Resources Author Services Accessibility API Access RSS feed Manage Cookie Preferences © Research Square 2026 | ISSN 2693-5015 (online) Privacy Policy Terms of Service Do Not Sell My Personal Information {"props":{"pageProps":{"initialData":{"identity":"rs-9021786","acceptedTermsAndConditions":true,"allowDirectSubmit":false,"archivedVersions":[],"articleType":"Research Article","associatedPublications":[],"authors":[{"id":606326175,"identity":"64049966-4f03-4f91-80d9-42535323e3d8","order_by":0,"name":"Moyna Kalia","email":"","orcid":"","institution":"Indian Institute of Technology Ropar","correspondingAuthor":false,"prefix":"","firstName":"Moyna","middleName":"","lastName":"Kalia","suffix":""},{"id":606326176,"identity":"5c16bdc5-d928-412a-985c-0c7768db60af","order_by":1,"name":"Akanksha Kapoor","email":"","orcid":"","institution":"Indian Institute of Technology Ropar","correspondingAuthor":false,"prefix":"","firstName":"Akanksha","middleName":"","lastName":"Kapoor","suffix":""},{"id":606326177,"identity":"231301ee-7581-470c-b374-250a5b9d54a3","order_by":2,"name":"Deeksha Pal","email":"","orcid":"","institution":"Post Graduate Institute of Medical Education and Research (PGIMER)","correspondingAuthor":false,"prefix":"","firstName":"Deeksha","middleName":"","lastName":"Pal","suffix":""},{"id":606326178,"identity":"476b17f5-7056-4dcc-b5a4-b3b35665a65b","order_by":3,"name":"Suman Dasgupta","email":"","orcid":"","institution":"Tezpur University","correspondingAuthor":false,"prefix":"","firstName":"Suman","middleName":"","lastName":"Dasgupta","suffix":""},{"id":606326179,"identity":"54fcb41e-1626-47ad-89b9-a0a42a76aaf0","order_by":4,"name":"Durba Pal","email":"data:image/png;base64,iVBORw0KGgoAAAANSUhEUgAAAZAAAAAyAQMAAABI0h/eAAAABlBMVEX///8AAABVwtN+AAAACXBIWXMAAA7EAAAOxAGVKw4bAAAA5UlEQVRIie2RLQvCQBjHH8utjK3eoeBXODGIQfwqG8IsinVxlkuCX8dgeMaFlX2AhQWHcMmgTcHg1DmD7CUa7leeF+7H84cD0Gj+EQTyqpaxDrDcOm0UYoYBlk47hTrPoQVWslSHK6R9wo5redmnKzDkAbJdtcKS+WiwATUQXTcPptQ4MD0Oblyt8MQj1ATZeSsoOcACwBX1CruDnAoWFop9ala6+RVX0E6h0IYrLFbGsMfVTJh5sBgVJ1RxrFOsyCPZyU8nWyM6nn1MuW3PsuxWoxTx8NO9vwkrX37Bn0aj0Wg0JQ+ABVm1/4Hc1QAAAABJRU5ErkJggg==","orcid":"","institution":"Indian Institute of Technology Ropar","correspondingAuthor":true,"prefix":"","firstName":"Durba","middleName":"","lastName":"Pal","suffix":""}],"badges":[],"createdAt":"2026-03-03 15:23:42","currentVersionCode":1,"declarations":"","doi":"10.21203/rs.3.rs-9021786/v1","doiUrl":"https://doi.org/10.21203/rs.3.rs-9021786/v1","draftVersion":[],"editorialEvents":[],"editorialNote":"","failedWorkflow":false,"files":[{"id":104785208,"identity":"06af0298-dd4e-4912-8ae2-a2339d8d48c0","added_by":"auto","created_at":"2026-03-17 08:09:53","extension":"pdf","order_by":1,"title":"","display":"","copyAsset":false,"role":"manuscript-pdf","size":1834224,"visible":true,"origin":"","legend":"","description":"","filename":"Apoptosis.pdf","url":"https://assets-eu.researchsquare.com/files/rs-9021786/v1_covered_b4596688-3385-4ce8-81bb-782f2ad23e3b.pdf"},{"id":104783282,"identity":"278d43e5-9ec1-4466-bce9-eb46991b13e2","added_by":"auto","created_at":"2026-03-17 07:58:32","extension":"pdf","order_by":0,"title":"","display":"","copyAsset":false,"role":"supplement","size":561076,"visible":true,"origin":"","legend":"","description":"","filename":"Supplementaryfinal.pdf","url":"https://assets-eu.researchsquare.com/files/rs-9021786/v1/b691d9916b92679d2e42cd3a.pdf"},{"id":104744586,"identity":"09382eca-1371-4f18-accb-c27f737ed98e","added_by":"auto","created_at":"2026-03-16 17:11:33","extension":"docx","order_by":1,"title":"","display":"","copyAsset":false,"role":"supplement","size":27414,"visible":true,"origin":"","legend":"","description":"","filename":"Supplementaryfinalapoptosis.docx","url":"https://assets-eu.researchsquare.com/files/rs-9021786/v1/a6a698e190f187cc57b0c9f7.docx"}],"financialInterests":"No competing interests reported.","formattedTitle":"AHSG confers apoptosis resistance in lung adenocarcinoma by modulating the GSK3β/β-catenin axis","fulltext":[],"fulltextSource":"","fullText":"","funders":[],"hasAdminPriorityOnWorkflow":false,"hasManuscriptDocX":false,"hasOptedInToPreprint":true,"hasPassedJournalQc":"","hasAnyPriority":false,"hideJournal":false,"highlight":"","institution":"","isAcceptedByJournal":false,"isAuthorSuppliedPdf":true,"isDeskRejected":"","isHiddenFromSearch":false,"isInQc":false,"isInWorkflow":false,"isPdf":true,"isPdfUpToDate":true,"isWithdrawnOrRetracted":false,"journal":{"display":true,"email":"[email protected]","identity":"apoptosis","isNatureJournal":false,"hasQc":true,"allowDirectSubmit":false,"externalIdentity":"appt","sideBox":"Learn more about [Apoptosis](http://link.springer.com/journal/10495)","snPcode":"10495","submissionUrl":"https://submission.nature.com/new-submission/10495/3","title":"Apoptosis","twitterHandle":"","acdcEnabled":true,"dfaEnabled":true,"editorialSystem":"em","reportingPortfolio":"Springer Hybrid","inReviewEnabled":true,"inReviewRevisionsEnabled":false},"keywords":"Lung adenocarcinoma, AHSG, GSK3β, glycoprotein, programmed cell death","lastPublishedDoi":"10.21203/rs.3.rs-9021786/v1","lastPublishedDoiUrl":"https://doi.org/10.21203/rs.3.rs-9021786/v1","license":{"name":"CC BY 4.0","url":"https://creativecommons.org/licenses/by/4.0/"},"manuscriptAbstract":"\u003cp\u003eRecent studies have demonstrated that alpha-2-Heremans-Schmid glycoprotein (AHSG) is significantly upregulated in lung adenocarcinoma (LUAD), where it correlates with poor prognosis and serves as an independent prognostic factor in LUAD patients. It promotes tumor progression by enhancing cell proliferation, migration, and invasion through modulation of TGFβ/PI3K-Akt signaling and induction of epithelial-mesenchymal transition (EMT). Although the proliferative effect of AHSG is well established, its role in regulating anti-apoptotic functions and the underlying molecular mechanisms remains unexplored. In the present study, we demonstrated that elevated cytoplasmic AHSG in LUAD serves as a critical regulator of programmed cell death by targeting the GSK3β/β-catenin axis. Mechanistically, cytoplasmic AHSG interacts with GSK3β and promotes its TRAF6-mediated ubiquitination and degradation, thereby relieving β-catenin repression and facilitating its nuclear translocation. Nuclear accumulation of β-catenin in LUAD cells considerably inhibits apoptosis, thereby promoting tumor survival. Interestingly, AHSG ablation markedly inhibited the GSK3β/β-catenin pathway, leading to induction of apoptosis in LUAD cells. These findings reveal a fundamental role of AHSG in driving LUAD cancer progression and suggest that targeting AHSG may be a potential therapeutic strategy for LUAD management.\u003c/p\u003e","manuscriptTitle":"AHSG confers apoptosis resistance in lung adenocarcinoma by modulating the GSK3β/β-catenin axis","msid":"","msnumber":"","nonDraftVersions":[{"code":1,"date":"2026-03-16 17:11:27","doi":"10.21203/rs.3.rs-9021786/v1","editorialEvents":[{"type":"communityComments","content":0},{"type":"decision","content":"Revision requested","date":"2026-04-11T11:50:28+00:00","index":"","fulltext":""},{"type":"editorInvitedReview","content":"","date":"2026-04-08T02:41:08+00:00","index":"hide","fulltext":""},{"type":"editorInvitedReview","content":"","date":"2026-03-31T14:55:42+00:00","index":"hide","fulltext":""},{"type":"reviewerAgreed","content":"44377066581499276495588588957186215087","date":"2026-03-19T01:39:30+00:00","index":"hide","fulltext":""},{"type":"reviewerAgreed","content":"112343106827734085304894518794108866531","date":"2026-03-16T04:03:19+00:00","index":"hide","fulltext":""},{"type":"reviewersInvited","content":"","date":"2026-03-13T10:50:28+00:00","index":"","fulltext":""},{"type":"editorAssigned","content":"","date":"2026-03-04T11:10:36+00:00","index":"","fulltext":""},{"type":"checksComplete","content":"","date":"2026-03-04T11:09:38+00:00","index":"","fulltext":""},{"type":"submitted","content":"Apoptosis","date":"2026-03-03T15:06:47+00:00","index":"","fulltext":""}],"status":"published","journal":{"display":true,"email":"[email protected]","identity":"apoptosis","isNatureJournal":false,"hasQc":true,"allowDirectSubmit":false,"externalIdentity":"appt","sideBox":"Learn more about [Apoptosis](http://link.springer.com/journal/10495)","snPcode":"10495","submissionUrl":"https://submission.nature.com/new-submission/10495/3","title":"Apoptosis","twitterHandle":"","acdcEnabled":true,"dfaEnabled":true,"editorialSystem":"em","reportingPortfolio":"Springer Hybrid","inReviewEnabled":true,"inReviewRevisionsEnabled":false}}],"origin":"","ownerIdentity":"e5297d97-4d8d-463c-b3fe-e428dfb62741","owner":[],"postedDate":"March 16th, 2026","published":true,"recentEditorialEvents":[],"rejectedJournal":[],"revision":"","amendment":"","status":"in-revision","subjectAreas":[],"tags":[],"updatedAt":"2026-04-11T11:55:14+00:00","versionOfRecord":[],"versionCreatedAt":"2026-03-16 17:11:27","video":"","vorDoi":"","vorDoiUrl":"","workflowStages":[]},"version":"v1","identity":"rs-9021786","journalConfig":"researchsquare"},"__N_SSP":true},"page":"/article/[identity]/[[...version]]","query":{"redirect":"/article/rs-9021786","identity":"rs-9021786","version":["v1"]},"buildId":"XKTyCvWXoU3ODBz1xrDgd","isFallback":false,"isExperimentalCompile":false,"dynamicIds":[84888],"gssp":true,"scriptLoader":[]}

Text is read by the "Ask this paper" AI Q&A widget below. Extraction quality varies by source — PMC NXML preserves structure cleanly, OA-HTML may include some navigation residue, and OA-PDF can have broken hyphenation. The publisher copy (via DOI) is the canonical version.

My notes (saved in your browser only)

Ask this paper AI returns verbatim quotes from the full text · source: preprint-html

Answers must be backed by verbatim quotes from this paper's full text. Hallucinated quotes are dropped automatically; if no verbatim passage answers the question, we say so. How this works

Citation neighborhood (no data yet)

We don't have any in-corpus citations linked to this paper yet. This is a recent paper (2026) — citers typically take a year or two to land, and the OpenAlex reference graph may still be filling in.

Source provenance

europepmc
last seen: 2026-05-20T01:45:00.602351+00:00